Dose-range Finding Treosulfan-based Conditioning

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2006

Conditions
Hematological Malignancies
Interventions
DRUG

Treosulfan

10 g/m² i.v. infusion, day -6, -5, -4

DRUG

Treosulfan

12 g/m² i.v. infusion, day -6, -5, -4

DRUG

Treosulfan

14 g/m² i.v. infusion, day -6, -5, -4

Trial Locations (7)

12203

Charité University Hospital Berlin, Berlin

18057

University Hospital Rostock, Rostock

20246

University Hospital Hamburg Eppendorf, Hamburg

90340

5th Medical Clinic, Clinic North, Nuremberg

FIN-00290

Helsinki University Central Hospital, Helsinki

40-029

Silesian Medical University, Katowice

141 86

Karolinska University Hospital & Karolinska Institute, Stockholm

All Listed Sponsors
lead

medac GmbH

INDUSTRY

NCT01063647 - Dose-range Finding Treosulfan-based Conditioning | Biotech Hunter | Biotech Hunter